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LETTER TO THE EDITOR

Regenerative Therapy by
Replacement of Stem Cells
in Females
Sir,

Primary ovarian failure (POF) or premature ovarian
insufficiency (POI) is the loss of function of the ovaries
before age 40, which can be idiopathic or as a result of
post-cancer treatments and radiations.1 There is no
proven effective means for treatment of POF in humans
and contemporary medicinal treatment does not show
certainty to fertility.2 Recent studies on stem cell
treatment were done by isolation of the oogonial stem
cells from the adult mouse and human ovaries, which
later demonstrated the capability of forming mature
oocytes showing potential and hopeful treatment of
infertility.2,3

Stem cells are acknowledged as progenitor cells with the
potential to proliferate and differentiate into specialized
cells of the body. The major sources of stem cells
include embryonic stem cells from human embryos and
adult stem cells from adult humans from body organs,
bone marrow or adipose tissue.3 The role of adipose
derived stem cells (ADCs) is identified in tissue
rejuvenation and restoration by being antiapoptotic,
immunomodulatory and hypoimmunogenic nature,
holding secretory exosomic neurotrophils and betacatenin protiens that have been shown to reverse the
disease signs in animal models of POF.4
ADCs are inoculated with the platelet rich plasma (PRP)
of the same subject containing vascular endothelial
growth factor (VEGF), fibroblast growth factors 2 and 8
(FGF2&8), sonic hedgehog (SHH) proteins, (important
for vertebrate organogenesis), exosomes and adhering
Wnt proteins leading to beta cantenin synthesis.4 The
interaction between Wnt/β-catenin allows the graffian
cells (GC) of the ovaries to express Notch signaling
pathways 1, 2 or 3 to sequel with oocyte-expressed
notch ligands like JAG1 and DLL3, that inhibit oocyte
apoptosis and stimulate GCs proliferation.5 ADCs may
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be injected into the ovaries of human POF patients
through ultrasound guidance technique with monitoring
through intricate biochemical analysis and biweekly
ultrasound scan of pelvis for the follicular generation.
Favorable results of the experiment may be incorporated
to improve infertility related issues other than POF in
human females. The return of reproductive functions can
then either be accomplished by natural manifestation of
pregnancy or assisted reproductive treatment, like
in vitro fertilization (IVF) and intracytoplasmic sperm
injection (ICSI).
Stem cell therapy may, therefore, be the imperative
technique for the return of fertility in those patients where
all the other treatment modalities have exhausted, thus
giving infertile couples a hope to smile.
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